Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

GSK Studentships

 

Global biopharma company GSK is investing up to £50 million in a collaboration with Oxford to advance the understanding of how cancer develops, which could inform future development of vaccines to prevent cancer. The agreement establishes the GSK-Oxford Cancer Immuno-Prevention Programme, aimed at exploring the potential of cancer prevention through vaccination.

 The programme leverages the complementary expertise of GSK and Oxford in the science of the immune system, vaccine development and cancer biology. It is hoped that the insights generated through the programme into how cancer develops could inform new approaches to vaccination for cancer prevention, offering fresh hope in the fight against the disease.

There are three GSK-Oxford DPhil studentships available for the 2025 intake. The project booklet for applicants to apply to can be accessed via the link below.

DPhil in Cancer Science - GSK Studentship Project Booklet 

Details on how to apply to these studentships can be found via the link below

https://www.ox.ac.uk/admissions/graduate/courses/cancer-science-biological

If you have any further questions about the programme or the application, please email cancer@medsci.ox.ac.uk